• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. Aggregation-induced chiral symmetry breaking of a naphthalimide–cyanostilbene dyad?
  Xin Li,Liangliang Zhu,Sai Duan,Yanli Zhao,Hans ?gren Phys. Chem. Chem. Phys., 2014,16, 23854-23860
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxamides and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxylic acids and derivatives Indolecarboxamides and derivatives

Chemical Profile of 1H-Indole-7-carboxamide (CAS No. 1670-89-9)

1H-Indole-7-carboxamide, with the chemical formula C9H7NO2, is a heterocyclic organic compound belonging to the indole family. This compound has garnered significant attention in the field of pharmaceutical chemistry due to its versatile structural framework, which makes it a valuable scaffold for drug discovery and development. The indole core is a prominent motif in many bioactive molecules, and modifications at the 7-position of the indole ring have been extensively explored for their potential pharmacological effects.

The CAS number 1670-89-9 provides a unique identifier for this compound, ensuring consistency and precision in scientific literature and industrial applications. As a derivative of indole, 1H-Indole-7-carboxamide exhibits properties that can be tailored for various therapeutic purposes. The amide functional group at the 7-position introduces reactivity and binding capabilities that are exploited in medicinal chemistry to enhance drug-target interactions.

In recent years, there has been a surge in research focusing on indole derivatives due to their reported biological activities. 1H-Indole-7-carboxamide has been investigated for its potential roles in modulating biological pathways associated with inflammation, neurodegeneration, and cancer. Its structural similarity to natural products and bioactive peptides makes it an attractive candidate for further derivatization and optimization.

One of the most compelling aspects of 1H-Indole-7-carboxamide is its adaptability as a pharmacophore. Researchers have demonstrated that slight modifications to the indole core or the amide group can significantly alter the compound's pharmacokinetic and pharmacodynamic profiles. For instance, studies have shown that substituents introduced at the 3-position or 5-position of the indole ring can enhance binding affinity to specific receptors or enzymes.

The pharmaceutical industry has leveraged these properties to develop novel therapeutic agents. 1H-Indole-7-carboxamide derivatives have been explored as potential treatments for neurological disorders, where the indole moiety is known to interact with neurotransmitter systems. Additionally, its amide group provides a site for further functionalization, allowing chemists to design molecules with improved solubility, bioavailability, and metabolic stability.

Recent advances in computational chemistry have further accelerated the discovery process for 1H-Indole-7-carboxamide derivatives. Molecular modeling techniques enable researchers to predict how different modifications will affect the compound's behavior within biological systems. This high-throughput screening approach has led to the identification of promising lead compounds that can be advanced into preclinical studies.

In clinical research, 1H-Indole-7-carboxamide has been studied for its potential anti-inflammatory properties. The indole scaffold is known to interact with nuclear receptors such as peroxisome proliferator-activated receptors (PPARs), which play a crucial role in regulating inflammatory responses. By modulating these pathways, derivatives of 1H-Indole-7-carboxamide may offer therapeutic benefits in conditions like rheumatoid arthritis or inflammatory bowel disease.

Another area of interest is the use of 1H-Indole-7-carboxamide in oncology research. Indole derivatives have been implicated in various mechanisms that contribute to cancer progression, including modulation of cell proliferation and apoptosis. Preclinical studies suggest that certain derivatives may inhibit tumor growth by disrupting key signaling pathways involved in cancer cell survival and metastasis.

The synthesis of 1H-Indole-7-carboxamide involves well-established organic chemistry protocols, making it accessible for large-scale production. The compound can be prepared through various synthetic routes, including cyclization reactions that construct the indole core followed by functionalization at the 7-position. Advances in synthetic methodologies have improved yield and purity, ensuring that researchers have reliable starting materials for their investigations.

Evaluation of 1H-Indole-7-carboxamide's safety profile is an essential step before advancing it into clinical trials. Toxicological studies have been conducted to assess its acute and chronic toxicity, as well as potential side effects. These assessments help determine appropriate dosing regimens and identify any liabilities that need to be addressed before human testing.

The growing body of research on 1H-Indole-7-carboxamide underscores its significance as a chemical entity with therapeutic potential. As our understanding of biological systems continues to evolve, so too will our ability to harness this compound's unique properties for treating human diseases. Collaborative efforts between academia and industry are essential to translate these findings into safe and effective treatments that improve patient outcomes.

• 1253792-04-9(4-Phenyl-1H-indole-7-carboxamide)
• 189812-79-1(3-methyl-1H-Indole-5-carboxamide)
• 321309-24-4(1H-Indole-7-carbohydrazide)
• 1670-85-5(1H-Indole-3-carboxylic Acid Amide)
• 1670-87-7(SD-169)
• 55706-61-1(quinoline-8-carboxamide)
• 744209-85-6(5-methyl-1H-Indole-3-carboxamide)
• 6480-67-7(3-Quinolinecarboxamide)
• 1211594-40-9(4-Hydroxy-1H-indole-7-carboxamide)
• 134767-27-4(4-Acridinecarboxamide)